Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
Author(s) -
Maria Souli,
Elisavet Konstantinidou,
IraMaria Tzepi,
Θωμάς Τσαγανός,
Angelos Pefanis,
Zoi Chryssouli,
Irene Galani,
Evangelos J. GiamarellosBourboulis,
Helen Giamarellou
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq470
Subject(s) - ertapenem , aztreonam , imipenem , meropenem , microbiology and biotechnology , carbapenem , escherichia coli , enterobacteriaceae , klebsiella pneumoniae , cephalosporin , medicine , biology , antibiotics , antibiotic resistance , biochemistry , gene
Although metallo-β-lactamases (MBLs) hydrolyse most β-lactams, including carbapenems, MBL-producing Enterobacteriaceae very often remain susceptible to carbapenems in vitro. We studied the in vivo efficacy of imipenem, meropenem, ertapenem and aztreonam against a carbapenem-susceptible MBL-producing clinical Escherichia coli strain in a rabbit intra-abdominal abscess model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom